BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34939938)

  • 1. Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa.
    Gordon DM; Beckers P; Castermans E; Neggers SJCMM; Rostomyan L; Bours V; Petrossians P; Dideberg V; Beckers A; Daly AF
    Endocr Connect; 2022 Jan; 11(1):. PubMed ID: 34939938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma.
    Fagundes GFC; Freitas-Castro F; Santana LS; Afonso ACF; Petenuci J; Funari MFA; Guimaraes AG; Ledesma FL; Pereira MAA; Victor CR; Ferrari MSM; Coelho FMA; Srougi V; Tanno FY; Chambo JL; Latronico AC; Mendonca BB; Fragoso MCBV; Hoff AO; Almeida MQ
    J Clin Endocrinol Metab; 2023 Jul; 108(8):2105-2114. PubMed ID: 36652439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients.
    Bayley JP; Grimbergen AE; van Bunderen PA; van der Wielen M; Kunst HP; Lenders JW; Jansen JC; Dullaart RP; Devilee P; Corssmit EP; Vriends AH; Losekoot M; Weiss MM
    BMC Med Genet; 2009 Apr; 10():34. PubMed ID: 19368708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma.
    Yonamine M; Wasano K; Aita Y; Sugasawa T; Takahashi K; Kawakami Y; Shimano H; Nishiyama H; Hara H; Naruse M; Okamoto T; Matsuda T; Kosugi S; Horiguchi K; Tanabe A; Watanabe A; Kimura N; Nakamura E; Sakurai A; Shiga K; Takekoshi K
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of metastatic pheochromocytoma and paraganglioma in
    Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
    J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Immunohistochemistry for SDHB in the Screening of Hereditary Pheochromocytoma-Paraganglioma.
    Choi HR; Koo JS; Lee CR; Lee JD; Kang SW; Jo YS; Chung WY
    Biology (Basel); 2021 Jul; 10(7):. PubMed ID: 34356532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion.
    Rijken JA; Niemeijer ND; Corssmit EP; Jonker MA; Leemans CR; Menko FH; Hensen EF
    Clin Genet; 2016 Jan; 89(1):128-32. PubMed ID: 25827221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study.
    Ma X; Li M; Tong A; Wang F; Cui Y; Zhang X; Zhang Y; Chen S; Li Y
    Front Endocrinol (Lausanne); 2020; 11():574662. PubMed ID: 33362715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas.
    Petenuci J; Guimaraes AG; Fagundes GFC; Benedetti AFF; Afonso ACF; Pereira MAA; Zerbini MCN; Siqueira S; Yamauchi F; Soares SC; Srougi V; Tanno FY; Chambo JL; Lopes RI; Denes FT; Hoff AO; Latronico AC; Mendonca BB; Fragoso MCBV; Almeida MQ
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):117-124. PubMed ID: 33745191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.
    Albattal S; Alswailem M; Moria Y; Al-Hindi H; Dasouki M; Abouelhoda M; Alkhail HA; Alsuhaibani E; Alzahrani AS
    Oncotarget; 2019 Oct; 10(57):5919-5931. PubMed ID: 31666924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDHB-Associated Paraganglioma Syndrome in Africa-A Need for Greater Genetic Testing.
    Siddiqui N; Seedat F; Bulbulia S; Mtshali NZ; Botha A; Krause A; Daya R; Bayat Z
    J Endocr Soc; 2021 Oct; 5(10):bvab111. PubMed ID: 34377882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel SDHB c.563 T > C mutation responsible for Paraganglioma syndrome and genetic analysis of the SDHB gene in China: a case report.
    Chen H; Yao W; He Q; Yu X; Bian B
    BMC Med Genet; 2020 May; 21(1):116. PubMed ID: 32460727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
    Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
    Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
    Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.
    Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of pheochromocytoma and paraganglioma in Spanish patients.
    Cascón A; Pita G; Burnichon N; Landa I; López-Jiménez E; Montero-Conde C; Leskelä S; Leandro-García LJ; Letón R; Rodríguez-Antona C; Díaz JA; López-Vidriero E; González-Neira A; Velasco A; Matias-Guiu X; Gimenez-Roqueplo AP; Robledo M
    J Clin Endocrinol Metab; 2009 May; 94(5):1701-5. PubMed ID: 19258401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
    Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
    Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
    de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
    Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.